These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12491624)

  • 1. [A study on the screening of prenatal trisomy 21 using the fucosylated alpha-fetoprotein ratio measured by a liquid-phase binding assay].
    Minobe S
    Hokkaido Igaku Zasshi; 2002 Nov; 77(6):527-32. PubMed ID: 12491624
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
    Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
    Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 4. [Screening for alpha-1-fetoprotein in maternal serum. Clinical and organizational aspects in the Central Bohemia Region].
    Stejskal D; Malbohan I
    Cesk Gynekol; 1988 Aug; 53(7):538-43. PubMed ID: 2458848
    [No Abstract]   [Full Text] [Related]  

  • 5. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 7. Maternal serum screening for neural tube defects and Down syndrome.
    Keith D
    Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964
    [No Abstract]   [Full Text] [Related]  

  • 8. [Does systemic determination of maternal serum alpha-1-fetoprotein have any value?].
    Muller F; Pantin G; Normand N; Bucheton D; Der Sarkissian H; Boué J; Giraudet P; Henrion R; Boué A
    Arch Fr Pediatr; 1990; 47(6):473-4. PubMed ID: 1698351
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
    Sritippayawan S; Vachirasrisoontra C
    J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
    Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
    J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
    [No Abstract]   [Full Text] [Related]  

  • 11. [Multiple of the median and its uses in antenatal screening].
    Jiangsu Province Birth Planning Commitee
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):428-9. PubMed ID: 15312334
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential pathways of testing after first-trimester screening for trisomy 21.
    Platt LD; Greene N; Johnson A; Zachary J; Thom E; Krantz D; Simpson JL; Silver RK; Snijders RJ; Goetzl L; Pergament E; Filkins K; Mahoney MJ; Hogge WA; Wilson RD; Mohide P; Hershey D; MacGregor S; Bahado-Singh R; Jackson LG; Wapner R;
    Obstet Gynecol; 2004 Oct; 104(4):661-6. PubMed ID: 15458882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of low serum alpha fetoprotein].
    Hod M; Friedman S; Pick I; Ovadia J
    Harefuah; 1989 Nov; 117(10):305-10. PubMed ID: 2482239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum screening of fetal chromosome abnormality during second pregnancy trimester: results of 26,803 pregnant women in Jiangsu Province].
    Hu YL;
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2476-80. PubMed ID: 18067809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A test system of prenatal screen for Down's syndrome].
    Jiang JP; Du M; Huang XY
    Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Mar; 29(2):109-11. PubMed ID: 16011115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for maternal serum alpha-fetoprotein: what about the low side?
    Lippman A; Evans JA
    CMAJ; 1987 Apr; 136(8):801-4. PubMed ID: 2436735
    [No Abstract]   [Full Text] [Related]  

  • 18. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
    Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters.
    Reynolds TM; Vranken G; Van Nueten J; Aldis J
    Int J Clin Pract; 2008 May; 62(5):735-43. PubMed ID: 17590221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal Down's screening test associated with severe hyperemesis gravidarum.
    Pradhan P; Mohajer M
    J Obstet Gynaecol; 2002 Nov; 22(6):692. PubMed ID: 12554274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.